Arabic Arabic English English French French German German
dark

Addex to Present at the Swiss Equities Baader Virtual Conference

Geneva, Switzerland,January 11, 2022 – Addex Therapeutics, a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced that CEO, Tim Dyer, will present at the Swiss Equities Baader Virtual Conference taking place January 12 – 14th, 2022. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Nearly 48,000 boosters given yesterday; 14 community cases; 34 people in hospital; two in ICU

Next Post

Ketamine and psychological therapy helped severe alcoholics abstain for longer in trial

Related Posts
Total
0
Share